MICHAEL DUNCAN: Open Payments
NPI 1679001622 · FLORENCE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,314 in 57 payments from 22 companies in 2025. Trend: 2023 $1,075 · 2024 $1,295 · 2025 $1,314
Food & beverage: $1,314
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $294 |
| ABBVIE INC. | 9 | $194 |
| Novo Nordisk Inc | 5 | $102 |
| Otsuka America Pharmaceutical, Inc. | 5 | $80 |
| Exact Sciences Corporation | 4 | $80 |
| Abbott Laboratories | 4 | $74 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $70 |
| Dexcom, Inc. | 2 | $55 |
| GlaxoSmithKline, LLC. | 3 | $53 |
| PFIZER INC. | 3 | $51 |
Products named: FARXIGA, VRAYLAR, AIRSUPRA, REXULTI, Cologuard Collection Kit, FREESTYLE LIBRE 3, Kerendia, Dexcom G6 Transmitter.
Industry payments across KY — which companies pay providers there.
